Literature DB >> 23769756

Position paper of the Italian Association for the Study of the Liver (AISF): the multidisciplinary clinical approach to hepatocellular carcinoma.

Luigi Bolondi, Umberto Cillo, Massimo Colombo, Antonio Craxì, Fabio Farinati, Edoardo G Giannini, Rita Golfieri, Massimo Levrero, Antonio Daniele Pinna, Fabio Piscaglia, Giovanni Raimondo, Franco Trevisani, Raffaele Bruno, Paolo Caraceni, Alessia Ciancio, Barbara Coco, Mirella Fraquelli, Maria Rendina, Giovanni Squadrito, Pierluigi Toniutto.   

Abstract

Patients with hepatocellular carcinoma should be managed with a multidisciplinary approach framed in a network where all the diagnostic techniques and therapeutic resources are available in order to provide the optimal level of care. Given this assumption, the Coordinating Committee of the Italian Association for the Study of the Liver nominated a panel of experts to elaborate practical recommendations for the multidisciplinary management of hepatocellular carcinoma aiming to provide: (1) homogeneous and efficacious diagnostic and staging work-up, and (2) the best treatment choice tailored to patient status and tumour stage at diagnosis. The 2010 updated American Association for the Study of Liver Disease Guidelines for hepatocellular carcinoma were selected as the reference document. For each management issue, the American Association for the Study of Liver Disease recommendations were briefly summarised and discussed, according to both the scientific evidence published after their release and the clinical expertise of the Italian centres taking care of these patients. The Italian Association for the Study of the Liver expert panel recommendations are finally reported.
Copyright © 2013 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cirrhosis; Hepatic resection; Hepatocellular carcinoma; Liver transplantation; Percutaneous ablation; Trans-arterial chemoembolisation

Mesh:

Year:  2013        PMID: 23769756     DOI: 10.1016/j.dld.2013.01.012

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  51 in total

1.  Application of the Barcelona Clinic Liver Cancer therapeutic strategy and impact on survival.

Authors:  Manuel Hernández-Guerra; Alejandro Hernández-Camba; Juan Turnes; Luis Martin Ramos; Laura Arranz; José Mera; Javier Crespo; Enrique Quintero
Journal:  United European Gastroenterol J       Date:  2015-06       Impact factor: 4.623

2.  Transarterial embolization combined with RNA interference targeting hypoxia-inducible factor-1α for hepatocellular carcinoma: a preliminary study of rat model.

Authors:  Jia-Yan Ni; Lin-Feng Xu; Wei-Dong Wang; Qiao-Sheng Huang; Hong-Liang Sun; Yao-Ting Chen
Journal:  J Cancer Res Clin Oncol       Date:  2016-09-16       Impact factor: 4.553

3.  Evaluation of Hepatocellular Carcinoma Transarterial Chemoembolization using Quantitative Analysis of 2D and 3D Real-time Contrast Enhanced Ultrasound.

Authors:  Kibo Nam; Maria Stanczak; Andrej Lyshchik; Priscilla Machado; Yuko Kono; Flemming Forsberg; Colette M Shaw; John R Eisenbrey
Journal:  Biomed Phys Eng Express       Date:  2018-04-18

Review 4.  Staging systems of hepatocellular carcinoma: a review of literature.

Authors:  Marcello Maida; Emanuele Orlando; Calogero Cammà; Giuseppe Cabibbo
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

5.  Contrast-enhanced ultrasound in the diagnosis of hepatocellular carcinoma.

Authors:  Vincenzo O Palmieri; Daniela Santovito; Giuseppe Marano; Francesco Minerva; Lara Ricci; Felicia D'Alitto; Giuseppe Angelelli; Giuseppe Palasciano
Journal:  Radiol Med       Date:  2015-01-20       Impact factor: 3.469

Review 6.  Image-guided therapies in the treatment of hepatocellular carcinoma: A multidisciplinary perspective.

Authors:  Jonathon Willatt; Kevin K Hannawa; Julie A Ruma; Timothy L Frankel; Dawn Owen; Pranab M Barman
Journal:  World J Hepatol       Date:  2015-02-27

Review 7.  Comparative analysis of current guidelines for the treatment of hepatocellular carcinoma.

Authors:  Francesco Tovoli; Giulia Negrini; Luigi Bolondi
Journal:  Hepat Oncol       Date:  2016-03-23

Review 8.  Laser ablation for small hepatocellular carcinoma: State of the art and future perspectives.

Authors:  Giovan Giuseppe Di Costanzo; Giampiero Francica; Claudio Maurizio Pacella
Journal:  World J Hepatol       Date:  2014-10-27

9.  Ramucirumab as a second-line treatment for hepatocellular carcinoma: reaching out further to patients with elevated alpha-fetoprotein.

Authors:  Edoardo G Giannini; Franco Trevisani
Journal:  Hepatobiliary Surg Nutr       Date:  2019-10       Impact factor: 7.293

10.  Optimized contrast-enhanced ultrasonography for characterization of focal liver lesions in cirrhosis: A single-center retrospective study.

Authors:  Ilario de Sio; Maddalena D Iadevaia; Luigi M Vitale; Marco Niosi; Anna Del Prete; Chiara de Sio; Lorenzo Romano; Annalisa Funaro; Rosaria Meucci; Alessandro Federico; Carmelina Loguercio; Marco Romano
Journal:  United European Gastroenterol J       Date:  2014-08       Impact factor: 4.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.